As SLAMF7 expression in macrophages was not determined in this clinical study, we cannot conclude whether SLAMF7 expression on this ADCP-mediating cell type plays a role in enhancing the elotuzumab-mediated elimination of SLAMF7+CD8+ T cells in MM patients. This evidence concerns the gene SLAMF7 and Miyoshi myopathy.